Engin Bermek

979 total citations
67 papers, 816 citations indexed

About

Engin Bermek is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Engin Bermek has authored 67 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 17 papers in Oncology and 13 papers in Immunology. Recurrent topics in Engin Bermek's work include RNA and protein synthesis mechanisms (19 papers), PARP inhibition in cancer therapy (13 papers) and Calcium signaling and nucleotide metabolism (12 papers). Engin Bermek is often cited by papers focused on RNA and protein synthesis mechanisms (19 papers), PARP inhibition in cancer therapy (13 papers) and Calcium signaling and nucleotide metabolism (12 papers). Engin Bermek collaborates with scholars based in Türkiye, Germany and Japan. Engin Bermek's co-authors include Rüstem Nurten, Heinrich Matthaei, Mamed Mustafaev, Beyazıt Çırakoğlu, Zehra Sayers, Zafer Gürel, Altan Erarslan, İşıl Albeniz, J Hradec and R A Berg and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Engin Bermek

65 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Engin Bermek Türkiye 17 551 181 136 93 58 67 816
S. Flodin Sweden 17 535 1.0× 196 1.1× 113 0.8× 75 0.8× 23 0.4× 22 841
M.N. Thang France 21 827 1.5× 236 1.3× 140 1.0× 15 0.2× 106 1.8× 70 1.1k
James J. Greene United States 15 378 0.7× 122 0.7× 51 0.4× 37 0.4× 27 0.5× 32 691
D. C. Livingston United Kingdom 16 660 1.2× 72 0.4× 99 0.7× 13 0.1× 78 1.3× 30 1000
Ljudmila Borissenko Germany 6 600 1.1× 37 0.2× 229 1.7× 24 0.3× 128 2.2× 7 830
Thomas J. Lobl United States 18 547 1.0× 57 0.3× 130 1.0× 11 0.1× 119 2.1× 42 1.1k
Margot G. Paulick United States 12 784 1.4× 91 0.5× 122 0.9× 16 0.2× 275 4.7× 14 1.1k
Peter J. Halbrooks United States 11 325 0.6× 59 0.3× 105 0.8× 17 0.2× 22 0.4× 12 776
Yoshimi Takata Japan 21 807 1.5× 45 0.2× 75 0.6× 26 0.3× 51 0.9× 37 1.1k
Hansruedi Kiefer United States 12 477 0.9× 559 3.1× 254 1.9× 21 0.2× 116 2.0× 14 1.2k

Countries citing papers authored by Engin Bermek

Since Specialization
Citations

This map shows the geographic impact of Engin Bermek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Engin Bermek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Engin Bermek more than expected).

Fields of papers citing papers by Engin Bermek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Engin Bermek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Engin Bermek. The network helps show where Engin Bermek may publish in the future.

Co-authorship network of co-authors of Engin Bermek

This figure shows the co-authorship network connecting the top 25 collaborators of Engin Bermek. A scholar is included among the top collaborators of Engin Bermek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Engin Bermek. Engin Bermek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nurten, Rüstem, et al.. (2004). Actin—an inhibitor of eukaryotic elongation factor activities. Biochemical and Biophysical Research Communications. 317(4). 1061–1066. 15 indexed citations
2.
Erçelen, Şebnem, et al.. (2003). Hemin‐dependent induction and internalization of CD38 in K562 cells. Journal of Cellular Biochemistry. 90(2). 379–386. 4 indexed citations
3.
Mustafaeva, Zeynep, et al.. (2000). Immune Response to 17β-Estradiol Involved in Polymer Gels: Antigen Specificity and Affinity of Hybridoma Clones. Hybridoma. 19(6). 495–499. 8 indexed citations
4.
Çırakoğlu, Beyazıt, et al.. (2000). Enhancement of the immune response to hepatitis B virus vaccine by antigen specific IgM. Immunology Letters. 73(1). 1–6. 4 indexed citations
5.
Nurten, Rüstem, et al.. (1999). On the Mode of Inhibition of Eukaryotic Protein Synthesis by ADP‐Ribosylation of Elongation Factor 2. IUBMB Life. 48(5). 557–562. 1 indexed citations
6.
Nurten, Rüstem, et al.. (1998). Interactions of elongation factor 2 with the cytoskeleton and interference with DNase I binding to actin. European Journal of Biochemistry. 256(1). 142–147. 12 indexed citations
7.
Bermek, Engin, et al.. (1998). Serum proteins with NAD+ glycohydrolase activity and anti-CD38 reactivity – elevated levels in serum of tumour patients. Cancer Letters. 126(1). 105–109. 2 indexed citations
8.
Albeniz, İşıl, Rüstem Nurten, & Engin Bermek. (1997). ADP-Ribosylation of Serum Proteins: Elevated Levels in Neoplastic Cases due to Altered NAD/ADP-Ribose Metabolism. Cancer Investigation. 15(3). 217–223. 5 indexed citations
9.
Bermek, Engin, et al.. (1996). Immune Response to 17β-Estradiol in Polyelectrolyte Complex: Antigen Specificity and Affinity of Hybridoma Clones. Hybridoma. 15(3). 233–238. 11 indexed citations
10.
Albeniz, İşıl, Rüstem Nurten, & Engin Bermek. (1996). ADP-ribosylation of serum proteins: evaluation as a potential tumor marker. Cancer Letters. 108(2). 239–245. 5 indexed citations
11.
Mustafaev, Mamed, et al.. (1996). Cu2+-mediated complex formation between polyacrylic acid (PAA) and bovine serum albumin. Journal of Immunological Methods. 197(1-2). 31–37. 20 indexed citations
12.
Nurten, Rüstem, et al.. (1994). Interactions of eukaryotic elongation factor 2 with actin: A possible link between protein synthetic machinery and cytoskeleton. FEBS Letters. 356(1). 89–93. 59 indexed citations
13.
Nurten, Rüstem, et al.. (1994). ADP-Ribosylation of Human Serum Proteins Promoted by Endogenous NAD Glycohydrolase Activity. Biochemical and Biophysical Research Communications. 200(1). 450–458. 10 indexed citations
14.
Moazami, Nader, et al.. (1994). β-Thalassemia in iran: A high incidence of the nonsense codon 39 mutation on the island of queshm. Hemoglobin. 18(6). 449–453. 21 indexed citations
15.
Bilgin, N., et al.. (1990). Binding of periodate-oxidized guanine nucleotides to eukaryotic elongation factor 2. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1048(2-3). 217–222. 3 indexed citations
16.
Dalay, Nejat, Betül Kırdar, & Engin Bermek. (1984). The effect of cycloheximide on nuclear uH2A content. Cellular and Molecular Life Sciences. 40(12). 1398–1399. 2 indexed citations
17.
Bermek, Engin, et al.. (1982). A translational inhibitor activated in rabbit reticulocyte lysates under high pO2. FEBS Letters. 145(1). 143–146. 9 indexed citations
18.
Bermek, Engin. (1974). Studies on the binding of ADP-ribosylated human translocation factor to ribosomes.. PubMed. 14. 308–13. 2 indexed citations
19.
Hradec, J, et al.. (1971). The role of cholesteryl 14-methylhexadecanoate in peptide elongation reactions. Biochemical Journal. 123(5). 959–966. 31 indexed citations
20.
Bermek, Engin & Heinrich Matthaei. (1970). Elongation factors from human lymphatic tissue: Isolation and some properties. FEBS Letters. 10(2). 121–124. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Flodin Breakdown of academic impact, for papers by M.N. Thang Breakdown of academic impact, for papers by James J. Greene Breakdown of academic impact, for papers by D. C. Livingston Breakdown of academic impact, for papers by Ljudmila Borissenko Breakdown of academic impact, for papers by Thomas J. Lobl Breakdown of academic impact, for papers by Margot G. Paulick Breakdown of academic impact, for papers by Peter J. Halbrooks Breakdown of academic impact, for papers by Yoshimi Takata Breakdown of academic impact, for papers by Hansruedi Kiefer
Rankless by CCL
2026